Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case
Author:
Funder
Processa Pharma
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. Treatment of refractory tumor necrosis factor inhibitor–induced palmoplantar pustulosis: a report of 2 cases;Chu;Arch Dermatol,2011
2. Jakpot! New small molecules in autoimmune and inflammatory diseases;Ghoreschi;Exp Dermatol,2014
3. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial;Bissonnette;J Eur Acad Dermatol Venereol,2014
4. Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis;Shibata;JAAD Case Rep,2019
5. Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: impact of this JAK inhibitor on T-cell differentiation;Koga;Clin Immunol,2016
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature;International Immunopharmacology;2024-09
2. Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial;American Journal of Clinical Dermatology;2024-07-02
3. Efficacy and Safety of JAK-Inhibitors in Treating Refractory Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2024-03-18
4. Therapieansprechen der palmoplantaren Pustulose auf Upadacitinib: eine Fallserie von fünf Patienten;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-11
5. Response of palmoplantar pustulosis to upadacitinib: A case series of five patients;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3